Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $16.1000 (6.03%) ($16.1000 - $16.1000) on Wed. Aug. 24, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.76% (three month average) | RSI | 33 | Latest Price | $16.1000(6.03%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.2% a day on average for past five trading days. | Weekly Trend | EDIT declines -9.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(60%) IWC(57%) IWO(54%) IWM(53%) IBUY(51%) | Factors Impacting EDIT price | EDIT will decline at least -2.88% in a week (0% probabilities). VIXM(-19%) UUP(-15%) TBT(-10%) VXX(-9%) EDOC(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.88% (StdDev 5.76%) | Hourly BBV | 1.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-0.09(-100.56%) | Resistance Level | $17.1 | 5 Day Moving Average | $15.33(5.02%) | 10 Day Moving Average | $16.47(-2.25%) | 20 Day Moving Average | $17.1(-5.85%) | To recent high | -16.7% | To recent low | 62.1% | Market Cap | $1000m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |